145 results on '"Watts, Gerald F."'
Search Results
2. ANGPTL3 and ApoC-III inhibitors for treating hypertriglyceridemia in context: horses for courses?
3. Addressing genetic and environmental sources of cardiometabolic disease
4. Editorial: Quantitative and qualitative aspects of lipids and lipoproteins in health and disease: nutrition, physiology and genetics
5. Adherence to pharmacotherapy: sine qua non for reducing cumulative risk of premature coronary disease in familial hypercholesterolemia
6. Lipoprotein(a) and calcific aortic valve disease: current evidence and future directions
7. Abstract 17120: ARO-ANG3, an Investigational RNAi Therapeutic, Silences the Expression of ANGPTL3 and Decreases Atherogenic Lipoproteins in Patients With Mixed Dyslipidemia: ARCHES-2 Study Results
8. Abstract 12103: Intraindividual Variability in Serial Lipoprotein(a) Concentration Among Placebo-Treated Patients in the OCEAN(a)-DOSE Trial
9. Xenosterolemia in clinical practice: what is in a name?
10. Microplastics, cardiometabolic risk, genetics and Alzheimerʼs disease
11. Hypertriglyceridemia: rationale, design and implementation of the Australian Hypertriglyceridemia Registry
12. Recent dynamic studies of the metabolism of atherogenic lipoproteins: elucidating the mode of action of new therapies
13. Splice correction therapies for familial hypercholesterolemic patients with low-density lipoprotein receptor mutations
14. Dyslipidaemia and cardiometabolic health: springboard for an emerging medical specialty?
15. Novel behavioural approaches and implementation science for mitigating genetic risk of cardiovascular disease due to elevated lipoprotein(a)
16. Best practice for treating dyslipidaemia in patients with diabetes based on current international guidelines
17. Lipoprotein (a) and diabetes mellitus: causes and consequences
18. Advances, gaps and opportunities in the detection of familial hypercholesterolemia: overview of current and future screening and detection methods
19. Advances, gaps and opportunities in the detection of familial hypercholesterolemia: overview of current and future screening and detection methods
20. Abstract 15751: Pharmacodynamic Effect of ARO-ANG3, an Investigational RNA Interference Targeting Hepatic Angiopoietin-like Protein 3, in Patients With Hypercholesterolemia
21. Abstract 13951: Safety, Tolerability and Efficacy of Single-dose Amg 890, a Novel Sirna Targeting Lp(a), in Healthy Subjects and Subjects With Elevated Lp(a)
22. Abstract 12594: Pharmacodynamic Effect of ARO-APOC3, an Investigational Hepatocyte-targeted RNA Interference Therapeutic Targeting Apolipoprotein C3, in Patients With Hypertriglyceridemia and Multifactorial Chylomicronemia
23. Metabolism of lipoprotein(a): new findings, implications and outstanding issues
24. The brave new world of genetic testing in the management of the dyslipidaemias
25. Editorial: New targets, treatments and trials for preventing and reversing atherosclerosis: the paradox of choice
26. Lipid management in people with peripheral artery disease
27. Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) and Statins on Postprandial Triglyceride-Rich Lipoprotein Metabolism
28. Statin Toxicity: Mechanistic Insights and Clinical Implications
29. Writing on the wall for precision medicine in the prevention of atherosclerotic cardiovascular disease
30. Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition and Statins on Postprandial Triglyceride-Rich Lipoprotein Metabolism
31. Acute Impact of Different Exercise Modalities on Arterial and Platelet Function
32. PCSK9 in context: A contemporary review of an important biological target for the prevention and treatment of atherosclerotic cardiovascular disease
33. The shape of things to come in lipid management: a feast of reason
34. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up
35. Beyond cascade screening: detection of familial hypercholesterolaemia at childhood immunization and other strategies
36. Mode of action of berberine on lipid metabolism: a new–old phytochemical with clinical applications?
37. Child–Parent Familial Hypercholesterolemia Screening in Primary Care
38. Factorial Effects of Evolocumab and Atorvastatin on Lipoprotein Metabolism
39. Challenges in the health economics of familial hypercholesterolemia
40. Recent explanatory trials of the mode of action of drug therapies on lipoprotein metabolism
41. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
42. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
43. A new electronic screening tool for identifying risk of familial hypercholesterolaemia in general practice
44. Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217
45. Initiation of PCSK9 inhibition in patients with heterozygous familial hypercholesterolaemia entering adulthood: a new design for living with a high-risk condition?
46. Statin therapy and plasma free fatty acids: a systematic review and meta-analysis of controlled clinical trials
47. ApoA-II HDL Catabolism and Its Relationships With the Kinetics of ApoA-I HDL and of VLDL1, in Abdominal Obesity
48. Developing role of microRNA-33 in lipid metabolism and atherosclerosis
49. Prevalence of Familial Hypercholesterolemia in Adolescents: Potential Value of Universal Screening?
50. The hinterland of familial hypercholesterolaemia: what do we not know?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.